| Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease SO Torres VE1, Chapman AB1, Devuyst O1, Gansevoort RT1, Perrone RD1, Koch G1 ... N Engl J Med. 377 (20), 1930-1942, 2017 | 601* | 2017 |
| Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss F Moreso, M Ibernon, M Goma, M Carrera, X Fulladosa, M Hueso, ... American Journal of Transplantation 6 (4), 747-752, 2006 | 376 | 2006 |
| Reliability of chronic allograft nephropathy diagnosis in sequential protocol biopsies D Serón, F Moreso, X Fulladosa, M Hueso, M Carrera, JM Grinyó Kidney international 61 (2), 727-733, 2002 | 167 | 2002 |
| Protocol renal allograft biopsies and the design of clinical trials aimed to prevent or treat chronic allograft NEPHROPATHY1 D Serón, F Moreso, JM Ramón, M Hueso, E Condom, X Fulladosa, ... Transplantation 69 (9), 1849-1855, 2000 | 158 | 2000 |
| Low-Dose Cyclosporine and Mycophenolate Mofetil in Renal Allograft Recipients With Suboptimal Renal Function1, 2 M Hueso, J Bover, D Serón, S Gil-Vernet, I Sabaté, X Fulladosa, R Ramos, ... Transplantation 66 (12), 1727-1731, 1998 | 138 | 1998 |
| Early subclinical rejection as a risk factor for late chronic humoral rejection F Moreso, M Carrera, M Goma, M Hueso, J Sellares, J Martorell, ... Transplantation 93 (1), 41-46, 2012 | 120 | 2012 |
| Serial protocol biopsies to quantify the progression of chronic transplant nephropathy in stable renal allografts F Moreso, M Lopez, A Vallejos, C Giordani, L Riera, X Fulladosa, ... American Journal of Transplantation 1 (1), 82-88, 2001 | 95 | 2001 |
| RECIPIENT BODY SURFACE AREA AS A PREDICTOR OF POSTTRANSPLANT RENAL ALLOGRAFT EVOLUTION1 F Moreso, D Serón, AI Anunciada, M Hueso, JM Ramón, X Fulladosa, ... Transplantation 65 (5), 671-676, 1998 | 91 | 1998 |
| Baseline immunosuppression is associated with histological findings in early protocol biopsies F Moreso, D Serón, M Carrera, S Gil-Vernet, JM Cruzado, M Hueso, ... Transplantation 78 (7), 1064-1068, 2004 | 73 | 2004 |
| Treatment of hypertension after renal transplantation: long-term efficacy of verapamil, enalapril, and doxazosin A Martínez-Castelao, M Hueso, V Sanz, J Rejas, J Alsina, JM Grinyó Kidney International 54, S130-S134, 1998 | 68 | 1998 |
| Prevention of cold ischaemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation. I Herrero, J Torras, M Riera, E Condom, O Coll, JM Cruzado, M Hueso, ... Nephrology, dialysis, transplantation: official publication of the European …, 1999 | 67 | 1999 |
| Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft. JM Grinyó, S Gil-Vernet, D Seron, M Hueso, X Fulladosa, JM Cruzado, ... Nephrology, dialysis, transplantation: official publication of the European …, 1998 | 62 | 1998 |
| Immunephenotype of glomerular and interstitial infiltrating cells in protocol renal allograft biopsies and histological diagnosis F Moreso, D Seron, F O'valle, M Ibernon, M Goma, M Hueso, JM Cruzado, ... American Journal of Transplantation 7 (12), 2739-2747, 2007 | 49 | 2007 |
| Influence of nephron mass in development of chronic renal failure after prolonged warm renal ischemia JM Cruzado, J Torras, M Riera, I Herrero, M Hueso, L Espinosa, ... American journal of physiology-Renal physiology 279 (2), F259-F269, 2000 | 47 | 2000 |
| Resistive index and chronic allograft nephropathy evaluated in protocol biopsies as predictors of graft outcome A Vallejos, G Alperovich, F Moreso, C Canas, ME de Lama, M Goma, ... Nephrology Dialysis Transplantation 20 (11), 2511-2516, 2005 | 46 | 2005 |
| Artificial intelligence for the artificial kidney: pointers to the future of a personalized hemodialysis therapy M Hueso, A Vellido, N Montero, C Barbieri, R Ramos, M Angoso, ... Kidney Diseases 4 (1), 1-9, 2018 | 45 | 2018 |
| Silencing of CD40 in vivo reduces progression of experimental atherogenesis through an NF-κB/miR-125b axis and reveals new potential mediators in the pathogenesis of … M Hueso, L De Ramon, E Navarro, E Ripoll, JM Cruzado, JM Grinyo, ... Atherosclerosis 255, 80-89, 2016 | 42 | 2016 |
| ncRNAs in therapeutics: challenges and limitations in nucleic acid-based drug delivery M Hueso, A Mallén, M Suñé-Pou, JM Aran, JM Suñé-Negre, E Navarro International journal of molecular sciences 22 (21), 11596, 2021 | 41 | 2021 |
| Dynamic variations of 3′ UTR length reprogram the mRNA regulatory landscape E Navarro, A Mallén, M Hueso Biomedicines 9 (11), 1560, 2021 | 34 | 2021 |
| Progress in the development and challenges for the use of artificial kidneys and wearable dialysis devices M Hueso, E Navarro, D Sandoval, JM Cruzado Kidney Diseases 5 (1), 3-10, 2019 | 33 | 2019 |
